With interest rates at record lows and possibly going lower in 2020, if I had $10,000 in a bank account I would consider putting it to work in the share market.
After all, the potential returns on offer are far greater than the paltry interest rates being offered by banks these days.
Here are three top shares I would consider buying in 2020:
Altium Limited (ASX: ALU)
I think Altium would be a great option for the $10,000. It is a leading design software company with a focus on printed circuit boards (PCBs). PCBs are the small circuit boards that you’ll find in most modern electronic devices. Altium has been experiencing incredible demand for its software in recent years thanks to the rapidly growing Internet of Things market. The good news is that this market is expected to grow rapidly, especially with the arrival of 5G internet. In light of this, I believe Altium is well-placed to continue its impressive form in 2020 and beyond.
Nearmap Ltd (ASX: NEA)
Another option for that $10,000 investment is this leading aerial imagery technology and location data company. As with Altium, I believe Nearmap is well-placed to grow its earnings at an explosive rate over the next few years. Especially following the release of new products which I believe strengthens its position as the market leader. Overall, I believe this places Nearmap perfectly to increase its share of the North American market. Management estimates that it has only captured 1% to 2% of this massive market.
ResMed Inc. (ASX: RMD)
A final option for the funds could be ResMed. It is a global medical device company which is focused on the growing sleep treatment market. I believe it has outstanding long term growth potential thanks to its leading position in a market poised to benefit greatly from the proliferation of obstructive sleep apnoea (OSA). According to a recent presentation, less than 20% of OSA sufferers have been diagnosed or treated. I feel this gives ResMed a significant runway for growth.
The post Where to invest $10,000 into ASX 200 shares in 2020 appeared first on Motley Fool Australia.
And at their dirt cheap prices, you would be crazy for missing out on these highly rated growth shares in 2020.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. The Motley Fool Australia owns shares of Altium. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019